180 related articles for article (PubMed ID: 34845242)
1. ASB2 is a novel E3 ligase of SMAD9 required for cardiogenesis.
Min KD; Asakura M; Shirai M; Yamazaki S; Ito S; Fu HY; Asanuma H; Asano Y; Minamino T; Takashima S; Kitakaze M
Sci Rep; 2021 Nov; 11(1):23056. PubMed ID: 34845242
[TBL] [Abstract][Full Text] [Related]
2. A label-free quantitative proteomics strategy to identify E3 ubiquitin ligase substrates targeted to proteasome degradation.
Burande CF; Heuzé ML; Lamsoul I; Monsarrat B; Uttenweiler-Joseph S; Lutz PG
Mol Cell Proteomics; 2009 Jul; 8(7):1719-27. PubMed ID: 19376791
[TBL] [Abstract][Full Text] [Related]
3. Smad9 is a new type of transcriptional regulator in bone morphogenetic protein signaling.
Tsukamoto S; Mizuta T; Fujimoto M; Ohte S; Osawa K; Miyamoto A; Yoneyama K; Murata E; Machiya A; Jimi E; Kokabu S; Katagiri T
Sci Rep; 2014 Dec; 4():7596. PubMed ID: 25534700
[TBL] [Abstract][Full Text] [Related]
4. Transcriptional factors smad1 and smad9 act redundantly to mediate zebrafish ventral specification downstream of smad5.
Wei CY; Wang HP; Zhu ZY; Sun YH
J Biol Chem; 2014 Mar; 289(10):6604-6618. PubMed ID: 24488494
[TBL] [Abstract][Full Text] [Related]
5. The E3 ubiquitin ligase specificity subunit ASB2beta is a novel regulator of muscle differentiation that targets filamin B to proteasomal degradation.
Bello NF; Lamsoul I; Heuzé ML; Métais A; Moreaux G; Calderwood DA; Duprez D; Moog-Lutz C; Lutz PG
Cell Death Differ; 2009 Jun; 16(6):921-32. PubMed ID: 19300455
[TBL] [Abstract][Full Text] [Related]
6. ASB2 targets filamins A and B to proteasomal degradation.
Heuzé ML; Lamsoul I; Baldassarre M; Lad Y; Lévêque S; Razinia Z; Moog-Lutz C; Calderwood DA; Lutz PG
Blood; 2008 Dec; 112(13):5130-40. PubMed ID: 18799729
[TBL] [Abstract][Full Text] [Related]
7. ASB2 is an Elongin BC-interacting protein that can assemble with Cullin 5 and Rbx1 to reconstitute an E3 ubiquitin ligase complex.
Heuzé ML; Guibal FC; Banks CA; Conaway JW; Conaway RC; Cayre YE; Benecke A; Lutz PG
J Biol Chem; 2005 Feb; 280(7):5468-74. PubMed ID: 15590664
[TBL] [Abstract][Full Text] [Related]
8. Notch-induced Asb2 expression promotes protein ubiquitination by forming non-canonical E3 ligase complexes.
Nie L; Zhao Y; Wu W; Yang YZ; Wang HC; Sun XH
Cell Res; 2011 May; 21(5):754-69. PubMed ID: 21119685
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological Manipulation of Early Zebrafish Skeletal Development Shows an Important Role for Smad9 in Control of Skeletal Progenitor Populations.
McDonald GLK; Wang M; Hammond CL; Bergen DJM
Biomolecules; 2021 Feb; 11(2):. PubMed ID: 33668680
[TBL] [Abstract][Full Text] [Related]
10. ECSASB2 mediates MLL degradation during hematopoietic differentiation.
Wang J; Muntean AG; Hess JL
Blood; 2012 Feb; 119(5):1151-61. PubMed ID: 22174154
[TBL] [Abstract][Full Text] [Related]
11. SCFFBXL¹⁵ regulates BMP signalling by directing the degradation of HECT-type ubiquitin ligase Smurf1.
Cui Y; He S; Xing C; Lu K; Wang J; Xing G; Meng A; Jia S; He F; Zhang L
EMBO J; 2011 May; 30(13):2675-89. PubMed ID: 21572392
[TBL] [Abstract][Full Text] [Related]
12. Phospho-Smad1 modulation by nedd4 E3 ligase in BMP/TGF-β signaling.
Kim BG; Lee JH; Yasuda J; Ryoo HM; Cho JY
J Bone Miner Res; 2011 Jul; 26(7):1411-24. PubMed ID: 21308777
[TBL] [Abstract][Full Text] [Related]
13. BMP-Smad 1/5/8 signalling in the development of the nervous system.
Hegarty SV; O'Keeffe GW; Sullivan AM
Prog Neurobiol; 2013 Oct; 109():28-41. PubMed ID: 23891815
[TBL] [Abstract][Full Text] [Related]
14. A Rare Mutation in SMAD9 Associated With High Bone Mass Identifies the SMAD-Dependent BMP Signaling Pathway as a Potential Anabolic Target for Osteoporosis.
Gregson CL; Bergen DJM; Leo P; Sessions RB; Wheeler L; Hartley A; Youlten S; Croucher PI; McInerney-Leo AM; Fraser W; Tang JC; Anderson L; Marshall M; Sergot L; Paternoster L; Davey Smith G; ; Brown MA; Hammond C; Kemp JP; Tobias JH; Duncan EL
J Bone Miner Res; 2020 Jan; 35(1):92-105. PubMed ID: 31525280
[TBL] [Abstract][Full Text] [Related]
15. Smad6 interacts with Runx2 and mediates Smad ubiquitin regulatory factor 1-induced Runx2 degradation.
Shen R; Chen M; Wang YJ; Kaneki H; Xing L; O'keefe RJ; Chen D
J Biol Chem; 2006 Feb; 281(6):3569-76. PubMed ID: 16299379
[TBL] [Abstract][Full Text] [Related]
16. BMP signaling controls muscle mass.
Sartori R; Schirwis E; Blaauw B; Bortolanza S; Zhao J; Enzo E; Stantzou A; Mouisel E; Toniolo L; Ferry A; Stricker S; Goldberg AL; Dupont S; Piccolo S; Amthor H; Sandri M
Nat Genet; 2013 Nov; 45(11):1309-18. PubMed ID: 24076600
[TBL] [Abstract][Full Text] [Related]
17. USP15 targets ALK3/BMPR1A for deubiquitylation to enhance bone morphogenetic protein signalling.
Herhaus L; Al-Salihi MA; Dingwell KS; Cummins TD; Wasmus L; Vogt J; Ewan R; Bruce D; Macartney T; Weidlich S; Smith JC; Sapkota GP
Open Biol; 2014 May; 4(5):140065. PubMed ID: 24850914
[TBL] [Abstract][Full Text] [Related]
18. Retinoic acid regulates bone morphogenic protein signal duration by promoting the degradation of phosphorylated Smad1.
Sheng N; Xie Z; Wang C; Bai G; Zhang K; Zhu Q; Song J; Guillemot F; Chen YG; Lin A; Jing N
Proc Natl Acad Sci U S A; 2010 Nov; 107(44):18886-91. PubMed ID: 20956305
[TBL] [Abstract][Full Text] [Related]
19. E3 ubiquitin ligase Smurf1 mediates core-binding factor alpha1/Runx2 degradation and plays a specific role in osteoblast differentiation.
Zhao M; Qiao M; Oyajobi BO; Mundy GR; Chen D
J Biol Chem; 2003 Jul; 278(30):27939-44. PubMed ID: 12738770
[TBL] [Abstract][Full Text] [Related]
20. Heart defects and embryonic lethality in Asb2 knock out mice correlate with placental defects.
Park SG; Kim EK; Nam KH; Lee JG; Baek IJ; Lee BJ; Nam SY
Cells Dev; 2021 Mar; 165():203663. PubMed ID: 33993984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
